With Approved Patents THC Therapeutics Inc (OTCMKTS: THCT) Goes Nuclear

With Approved Patents THC Therapeutics Inc (OTCMKTS: THCT) Goes Nuclear

SHARE

THC Therapeutics Inc (OTCMKTS: THCT) is cresting near $17 today. The stock did a reverse split earlier in the year, but aside from that THCT still stands up 60% over the last two days.

The driver for this positive action is a series of patents protecting the company’s cannabis quick-dryer, the dHydronator. The device sanitizes – tested to remove malicious funguses and contaminants like pesticides – and also dries at accelerated rates. Sanitized cannabis is an important issue in the sector that does not get a lot of attention.

In California, testing lab Steep Hill recently released a scathing report detailing a discovery that nearly 85% of cannabis clones in the state were contaminated with pesticide residue. The report detected Myclobutanil, a fungicide that is currently banned in Canada along with Colorado, Oregon and Washington.

THC Therapeutics Inc (OTCMKTS: THCT) is focused on developing The dHydronator®, a sanitizing herb dryer. The main function of The dHydronator® is to greatly accelerate the drying time of a herb while sanitizing it. The dHydronator® can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis, and it will reduce the drying time for cannabis from 10-14 days to less than 14 hours. The Company plans to also focus some of its future operations on participation in cannabis testing lab facilities and developing personal wellness centers. The Company is seeking partnerships, in the Cannabis & Health/Wellness industries in the United States & Canada.

Find out when $THCT reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.


“I could not be more elated that the US Patent and Trademark Office has accepted all 20 of the claims for the dHydronator®, Brandon Romanek, the company’s Founder and
CEO, stated in the company press release. “While we expected patent protection, we did not expect to receive such broad protection on our intellectual property. Many experts in the Cannabis industry liked our technology; however, they expressed serious doubts that we would receive any type of patent protection—much less the protection afforded by all 20 of our claims.”

The dHydronator is a fast-drying solution that achieves industry standards in under 14 hours. Furthermore, the patented herb dryer keeps cannabis’ integrity intact by not reducing the THC content level as the plant passes from wet to dry.

As a comparison, traditional drying methods like air drying can take up to two weeks. Some growers have even resorted to crude methods like putting cannabis strains in the microwave or the oven, which can seriously damage the plant. THC Therapeutics has eliminated those dramatic methods with one revolutionary product.

THC Therapeutics Inc (OTCMKTS: THCT) has a market cap of $218.41M and the company is riding high and we imagine a stoppage is coming at some point, but this technology is legitimate and could either lead to a consumer product on the horizon or being bought by a larger company in the space.

Sign-up for continuing coverage on shares of $THCT stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Sign Up for our 100% FREE Oracle Dispatch Newsletter

SHARE
Previous articleCBD Stock: CV Sciences Inc (OTCMKTS:CVSI) Stock Consolidates, What Next?
Next articleHow Medipharm Labs Corp (OTCMKTS:MLCPF) Just Took Over the Party in Cannabis